Sinogliatin

CAS No. 1191996-10-7

Sinogliatin( Dorzagliatin | HMS-5552 | RO-5305552 )

Catalog No. M10662 CAS No. 1191996-10-7

Sinogliatin (Dorzagliatin, HMS-5552, RO-5305552) is a novel, first-in-class glucokinase activator (GKS) to treat diabetes mellitus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Sinogliatin
  • Note
    Research use only, not for human use.
  • Brief Description
    Sinogliatin (Dorzagliatin, HMS-5552, RO-5305552) is a novel, first-in-class glucokinase activator (GKS) to treat diabetes mellitus.
  • Description
    Sinogliatin (Dorzagliatin, HMS-5552, RO-5305552) is a novel, first-in-class glucokinase activator (GKS) to treat diabetes mellitus.Diabetes Phase 3 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Dorzagliatin | HMS-5552 | RO-5305552
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Glucokinase
  • Research Area
    Metabolic Disease
  • Indication
    Diabetes

Chemical Information

  • CAS Number
    1191996-10-7
  • Formula Weight
    462.93
  • Molecular Formula
    C22H27ClN4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)C[C@H](N1CC(OC2=CC=CC=C2Cl)=CC1=O)C(NC3=NN(C[C@H](O)CO)C=C3)=O
  • Chemical Name
    (S)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-N-(1-((S)-2,3-dihydroxypropyl)-1H-pyrazol-3-yl)-4-methylpentanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Song L, et al. Clin Pharmacokinet. 2018 Oct;57(10):1307-1323.
molnova catalog
related products
  • AMG-3969

    AMG-3969 is an effective glucokinase-glucokinase regulatory protein interaction (GK-GKRP) disruptor (IC50: 4 nM).

  • Acarbose

    Acarbose is an inhibitor of intestinal alpha-glucosidase, used to treat type 2 diabetes mellitus.

  • POMHEX

    Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and selective ENO2 inhibitor.